- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 11.12M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $25.84M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $12.48M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $29.98M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $12.96M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $30.52M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $38.63M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $56.66M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $47.48M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $65.95M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 10.34M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $213K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.95M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $18.06M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $14.22M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.10 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.10 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $2.05M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $211K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.04M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.73M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $535K |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $3.32M |